BlackRock’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.1K Sell
19,028
-9,833
-34% -$25.7K ﹤0.01% 5230
2026
Q1
$65.5K Buy
28,861
+923
+3% +$2.62K ﹤0.01% 5059
2025
Q4
$84.1K Buy
27,938
+426
+2% +$1.39K ﹤0.01% 4943
2025
Q3
$102K Sell
27,512
-5,654
-17% -$20.4K ﹤0.01% 4820
2025
Q2
$132K Buy
33,166
+852
+3% +$3.82K ﹤0.01% 4772
2025
Q1
$155K Sell
32,314
-1,471
-4% -$7.5K ﹤0.01% 4652
2024
Q4
$174K Buy
33,785
+102
+0.3% +$659 ﹤0.01% 4651
2024
Q3
$251K Buy
33,683
+6,670
+25% +$52.3K ﹤0.01% 4480
2024
Q2
$219K Buy
27,013
+2,569
+11% +$18.7K ﹤0.01% 4531
2024
Q1
$183K Sell
24,444
-621
-2% -$4.72K ﹤0.01% 4607
2023
Q4
$170K Sell
25,065
-182
-0.7% -$1.21K ﹤0.01% 4678
2023
Q3
$164K Sell
25,247
-637
-2% -$3.73K ﹤0.01% 4729
2023
Q2
$142K Buy
25,884
+803
+3% +$5.46K ﹤0.01% 4825
2023
Q1
$236K Buy
25,081
+1,100
+5% +$12.1K ﹤0.01% 4730
2022
Q4
$280K Sell
23,981
-1,295
-5% -$14.3K ﹤0.01% 4756
2022
Q3
$282K Buy
25,276
+14,598
+137% +$195K ﹤0.01% 4885
2022
Q2
$136K Buy
+10,678
New +$93.4K ﹤0.01% 5144
2020
Q3
Sell
-70,615
Closed -$214K 5089
2020
Q2
$214K Hold
70,615
﹤0.01% 4362
2020
Q1
$111K Hold
70,615
﹤0.01% 4333
2019
Q4
$252K Hold
70,615
﹤0.01% 4291
2019
Q3
$215K Sell
70,615
-3,129
-4% -$9.85K ﹤0.01% 4320
2019
Q2
$162K Sell
73,744
-7,822
-10% -$24.8K ﹤0.01% 4397
2019
Q1
$292K Sell
81,566
-756
-0.9% -$2.63K ﹤0.01% 4183
2018
Q4
$200K Sell
82,322
-32,307
-28% -$154K ﹤0.01% 4234
2018
Q3
$818K Sell
114,629
-1,762
-2% -$15.5K ﹤0.01% 4009
2018
Q2
$1.29M Sell
116,391
-53,088
-31% -$543K ﹤0.01% 3867
2018
Q1
$1.55M Sell
169,479
-21,573
-11% -$197K ﹤0.01% 3764
2017
Q4
$1.81M Sell
191,052
-19,832
-9% -$200K ﹤0.01% 3724
2017
Q3
$2.26M Sell
210,884
-5,636
-3% -$51.9K ﹤0.01% 3676
2017
Q2
$2.23M Sell
216,520
-14,097
-6% -$178K ﹤0.01% 3659
2017
Q1
$3.23M Buy
230,617
+229,881
+31,234% +$3.5M ﹤0.01% 3517
2016
Q4
$11K Sell
736
-203
-22% -$3.08K ﹤0.01% 3370
2016
Q3
$15K Hold
939
﹤0.01% 3338
2016
Q2
$15K Buy
939
+584
+165% +$10.3K ﹤0.01% 3329
2016
Q1
$10K Buy
355
+224
+171% +$6.88K ﹤0.01% 3157
2015
Q4
$5K Hold
131
﹤0.01% 3143
2015
Q3
$5K Hold
131
﹤0.01% 3006
2015
Q2
$8K Hold
131
﹤0.01% 2916
2015
Q1
$11K Hold
131
﹤0.01% 2677
2014
Q4
$11K Hold
131
﹤0.01% 2705
2014
Q3
$8K Hold
131
﹤0.01% 2859
2014
Q2
$9K Hold
131
﹤0.01% 2848
2014
Q1
$12K Hold
131
﹤0.01% 2608
2013
Q4
$11K Hold
131
﹤0.01% 2659
2013
Q3
$12K Hold
131
﹤0.01% 2537
2013
Q2
$11K Buy
+131
New +$10.8K ﹤0.01% 2585

Other funds holding HHS

BlackRock's HHS Position: Q2 2026 in Review

BlackRock reduced its Harte-Hanks (HHS) stake by 34% in Q2 2026, selling an estimated $25.7K and leaving 19,028 shares worth $41.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5230.

BlackRock first reported a position in HHS in Q2 2013 and has held it in 46 quarters since. The position peaked at $3.23M in Q1 2017. 22 funds tracked by Wall St. Rank hold HHS as of Q2 2026.

  • BlackRock held 19,028 shares of Harte-Hanks worth $41.1K as of Q2 2026.
  • BlackRock sold 9,833 Harte-Hanks shares in Q2 2026, an estimated $25.7K.
  • Harte-Hanks made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #5230 holding.
  • BlackRock first reported a position in Harte-Hanks in Q2 2013 and has held it in 46 quarters since.
  • BlackRock's Harte-Hanks position peaked at $3.23M in Q1 2017.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.